SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-036661
Filing Date
2020-06-15
Accepted
2020-06-15 17:03:32
Documents
1
Period of Report
2020-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5852
  Complete submission text file 0001209191-20-036661.txt   7260
Mailing Address C/O ORCHARD THERAPEUTICS 101 SEAPORT BOULEVARD, 7TH FLOOR BOSTON MA 02210
Business Address
THOMAS FRANK E (Reporting) CIK: 0001242616 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38722 | Film No.: 20964097

Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700
Orchard Therapeutics plc (Issuer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000
SIC: 2836 Biological Products, (No Diagnostic Substances)